Ashland Signs Definitive Agreement To Sell Avoca Business To Mane; Expected To Close In Q1 2025; No Financial Terms Disclosed
Ashland Signs Definitive Agreement To Sell Avoca Business To Mane; Expected To Close In Q1 2025; No Financial Terms Disclosed
Wilmington, Del., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that it has signed a definitive agreement to sell its Avoca business to Mane. The transaction is expected to close in the calendar first quarter 2025, subject to the satisfaction of customary closing conditions.
特拉華州威爾明頓，2024年12月23日（GLOBE NEWSWIRE）—— Ashland Inc.（紐交所代碼：ASH）今天宣佈已簽署一項最終協議，將其Avoca業務出售給Mane。該交易預計將在2025年第一季度的日歷內完成，前提是滿足慣例的交割條件。
Ashland's Avoca business supplies Sclareolide, a fragrance fixative, and a range of contract manufacturing capabilities from two production facilities in North Carolina and Wisconsin. The Avoca business line represents the last entity from Ashland's previous acquisition of Pharmachem.
Ashland的Avoca業務提供香料定香劑Sclareolide，以及來自北卡羅來納州和威斯康星州兩個生產設施的區間合同製造能力。Avoca業務線代表了Ashland之前收購Pharmachem的最後一項實體。
譯文內容由第三人軟體翻譯。
